Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Camilo Ruiz

Sleep Medicine Fort Lauderdale, FL Doctor of Osteopathy

NPI 1063664696 CMS profile 678765

1319 Se 2Nd Ave, Fort Lauderdale, FL 33316

Open in the dashboard

General payments

$135,855

291 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Camilo Ruiz of Fort Lauderdale, FL is reported in the CMS Open Payments database as having received $135,855 across 291 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Sleep Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $84,504 148
2024 General $1,004 28
2023 General $26,403 48
2022 General $8,527 24
2021 General $9,290 25
2020 General $4,861 11
2019 General $1,265 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Camilo Ruiz
  • Sleep Medicine median
  • Middle half of Sleep Medicine
  • National median

In program year 2025, general payments to Camilo Ruiz were reported at $84,504. Among 670 Sleep Medicine profiles paid that year, the median was $439 and the middle half received between $127 and $1,274.

Show as a table
Year Camilo Ruiz Sleep Medicine median Middle half National median
2019 $1,265 $185 $66–$736 $163
2020 $4,861 $149 $46–$504 $114
2021 $9,290 $191 $62–$750 $132
2022 $8,527 $246 $92–$972 $149
2023 $26,403 $321 $119–$1,033 $160
2024 $1,004 $393 $111–$1,207 $164
2025 $84,504 $439 $127–$1,274 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Lilly USA, LLC $83,233 125 payments
  2. Idorsia Pharmaceuticals US Inc $32,328 53 payments
  3. Eisai Inc. $12,761 28 payments
  4. Inspire Medical Systems, Inc. $2,932 6 payments
  5. Harmony Biosciences LLC $1,336 35 payments
  6. Jazz Pharmaceuticals Inc. $1,221 24 payments
  7. Watermark Medical, Inc. $1,173 5 payments
  8. Avadel CNS Pharmaceuticals, LLC $259 3 payments
  9. Janssen Biotech, Inc. $146 1 payment
  10. Portola Pharmaceuticals, Inc. $126 1 payment
  11. Other $339 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $117,620 100 payments
  2. Travel and Lodging $7,625 63 payments
  3. Food and Beverage $7,553 122 payments
  4. Consulting Fee $2,955 4 payments
  5. Education $90 1 payment
  6. Gift $12 1 payment
Products named General payments · program years 2019–2025
  1. ZEPBOUND $81,360 120 payments
  2. QUVIVIQ $32,328 53 payments
  3. Dayvigo $12,761 28 payments
  4. Inspire Upper Airway Stimulation System $2,932 6 payments
  5. ARES HOME SLEEP TESTING DEVICE $1,173 5 payments
  6. XYWAV $942 20 payments
  7. Wakix Neurological Disorders $413 9 payments
  8. WAKIX Narcoplepsy $336 10 payments
  9. WAKIX Sleep Medicine $313 10 payments
  10. WAKIX Narcolepsy $275 6 payments
  11. Other $1,407 26 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 21 drugs

Part D claims

364

Median for Internal Medicine: 777

Drug cost

$22,257

Median for Internal Medicine: $73,373

Branded share of claims

12.1%

Median for Internal Medicine: 19.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 21 $12,862
Spiriva Handihaler Tiotropium Bromide Brand 11 $5,172
Rosuvastatin Calcium Generic 24 $784
Nifedipine Er Nifedipine Brand 12 $488
Armodafinil Generic 16 $437
Zolpidem Tartrate Generic 13 $262
Haloperidol Generic 13 $247
Atorvastatin Calcium Generic 32 $228
Levothyroxine Sodium Generic 26 $223
Lorazepam Generic 20 $214

The 10 drugs with the highest cost, of 21 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 104,182 Part D prescribers listed as Internal Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 21 billing codes

Paid by Medicare

$154,210

Medicare's payments for the services billed

Medicare patients

343

Average age 74

Services billed

1,930

117 women, 226 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 53%
Arthritis 53%
Diabetes 43%
Atrial fibrillation 43%
Chronic kidney disease 41%
Heart failure 37%
Depression 34%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

5 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XYWAV
  • JAZZ PHARMACEUTICALS INC. $357
$357 — —
WAKIX
  • Harmony Biosciences LLC $336
$336 — —
QUVIVIQ
  • IDORSIA PHARMACEUTICALS US INC $88
$88 — —
LUMRYZ
  • Avadel CNS Pharmaceuticals, LLC $26
$26 — —
Sunosi
  • Axsome Therapeutics, Inc. $18
$18 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

291 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sleep Medicine in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record